Private insurance coverage varies wildly: Some plans cover Wegovy or Zepbound for weight loss (usually with prior authorization) Many plans only cover Ozempic/Mounjaro if you have type 2 diabetes Some plans have exclusions for weight loss medications entirely Coverage may require documented BMI thresholds, previous diet attempts, or other criteria If your insurance covers brand-name medications for weight loss: Your copay might be $25-$100/month, which is obviously the best financial option
GLP-1 medications may contribute to this by slowing down digestion
The plotter confirms this is not imagined
There are oral medications, such as a newly FDA-approved Wegovy pill, which my insurance doesnt cover, either
This medication belongs to a class of drugs known as GLP-1 receptor agonists
If current trends persist, hospitals may find themselves over-leveraged on revenue streams that are no longer anchored in surgical volume but instead in revenue derived from specialty drug dispensing a model that may face future uncertainty as payer policies and pharmaceutical manufacturer strategies evolve